ARCHIVES

Pfizer’s Inlyta Gives FDA a Teaching Moment: Not All PFS Advantages Are Created Equal

This article is from The Cancer Letter archive.

Vol. 37 No. 46 | December 16, 2011

Download PDF Visit The Full Archive

Related Articles

CALGB Chairman Schilsky To Step Down After 15 Years Leading Cooperative Group.

February 1, 2008

In Brief: ASCO Congratulates Klausner; UCLA Names Gasson Head Of Jonsson Center

August 4, 1995

In Brief: Longmire Reappointed to Panel; New Organ System Group For Brain-CNS Tumors Asked

April 26, 1985

ASCO Objects To Proposed Graduate Medical Education Bill

September 20, 1985

Dasatinib, Nilotinib Show Strong Early Results As Frontline Therapy For CML

December 28, 2007

Also NCI appoints members of Clinical Trials Working Group to review trials system.

January 9, 2004